Newsroom Archives - Page 2 of 13 - Merck Animal Health USA

December 12, 2025

Merck Animal Health Announces Availability of Circumvent® CL, a Ready-to-use Vaccine Protecting Pigs Against Porcine Circovirus Types 2a and 2d and Lawsonia intracellularis

December 4, 2025

FDA Conditionally Approves Merck Animal Health’s EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)

November 6, 2025

Merck Animal Health Donates $20,000 to the University of Nebraska–Lincoln Klosterman Feedlot Innovation Center to Advance Sustainability-focused Research for Feedlot Cattle

September 25, 2025

New Study Confirms Rapid Action of PROTAZIL® (1.56% diclazuril) Antiprotozoal Pellets for the Treatment of Equine Protozoal Myeloencephalitis (EPM)

September 16, 2025

Merck Animal Health Partners with the American Association of Bovine Practitioners Foundation to Award $90,000 in Scholarships to Nine Promising Bovine Veterinary Students

September 15, 2025

Dr. Hunter Lang Named 2025 Mentor of the Year Posthumously by Merck Animal Health and the American Association of Bovine Practitioners

August 19, 2025

Merck Animal Health Reaches Unprecedented Milestone of 2 Million Cows Monitored with SenseHub® Dairy Technology

August 14, 2025

Now available: Intranasal BRD vaccine against both viral and bacterial pneumonia

August 4, 2025

Merck Animal Health Awards $50,000 in Scholarships to Next Generation Poultry Veterinarians

July 18, 2025

Merck Animal Health Announces FDA Approval of EXZOLT™ (fluralaner oral solution) for Chickens, the First Systemic Treatment for Northern Fowl Mites

July 10, 2025

FDA Approves BRAVECTO® QUANTUM (Fluralaner for Extended-Release Injectable Suspension) from Merck Animal Health

May 23, 2025

VCCA Article – Majority of Americans are “Meat Eaters”

12 3…11 Next